Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

A Ternary Mixture of Common Chemicals Perturbs Benign Human Breast Epithelial Cells More Than the Same Chemicals Do Individually.

Dairkee SH, Luciani-Torres G, Moore DH, Jaffee IM, Goodson WH 3rd.

Toxicol Sci. 2018 Sep 1;165(1):131-144. doi: 10.1093/toxsci/kfy126.

2.

Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation.

Schwarzman MR, Ackerman JM, Dairkee SH, Fenton SE, Johnson D, Navarro KM, Osborne G, Rudel RA, Solomon GM, Zeise L, Janssen S.

Environ Health Perspect. 2015 Dec;123(12):1255-64. doi: 10.1289/ehp.1408337. Epub 2015 Jun 2. Review.

3.

Exposure to the polyester PET precursor--terephthalic acid induces and perpetuates DNA damage-harboring non-malignant human breast cells.

Luciani-Torres MG, Moore DH, Goodson WH 3rd, Dairkee SH.

Carcinogenesis. 2015 Jan;36(1):168-76. doi: 10.1093/carcin/bgu234. Epub 2014 Nov 19.

4.

Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.

Zhang H, Cohen AL, Krishnakumar S, Wapnir IL, Veeriah S, Deng G, Coram MA, Piskun CM, Longacre TA, Herrler M, Frimannsson DO, Telli ML, Dirbas FM, Matin AC, Dairkee SH, Larijani B, Glinsky GV, Bild AH, Jeffrey SS.

Breast Cancer Res. 2014 Apr 7;16(2):R36. doi: 10.1186/bcr3640.

5.

Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells.

Sayeed A, Luciani-Torres G, Meng Z, Bennington JL, Moore DH, Dairkee SH.

PLoS One. 2013 Jun 20;8(6):e67191. doi: 10.1371/journal.pone.0067191. Print 2013.

6.

Bisphenol-A-induced inactivation of the p53 axis underlying deregulation of proliferation kinetics, and cell death in non-malignant human breast epithelial cells.

Dairkee SH, Luciani-Torres MG, Moore DH, Goodson WH 3rd.

Carcinogenesis. 2013 Mar;34(3):703-12. doi: 10.1093/carcin/bgs379. Epub 2012 Dec 7.

7.

Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines.

Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, Deng G, Telli ML, Advani RH, Carlson RW, Mollick JA, Sheth S, Kurian AW, Ford JM, Stockdale FE, Quake SR, Pease RF, Mindrinos MN, Bhanot G, Dairkee SH, Davis RW, Jeffrey SS.

PLoS One. 2012;7(5):e33788. doi: 10.1371/journal.pone.0033788. Epub 2012 May 7.

8.

Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women.

Goodson WH 3rd, Luciani MG, Sayeed SA, Jaffee IM, Moore DH 2nd, Dairkee SH.

Carcinogenesis. 2011 Nov;32(11):1724-33. doi: 10.1093/carcin/bgr196. Epub 2011 Sep 1.

9.

Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cells.

Luciani MG, Seok J, Sayeed A, Champion S, Goodson WH, Jeffrey SS, Xiao W, Mindrinos M, Davis RW, Dairkee SH.

PLoS One. 2011;6(5):e20016. doi: 10.1371/journal.pone.0020016. Epub 2011 May 19.

10.

Negative regulation of UCP2 by TGFβ signaling characterizes low and intermediate-grade primary breast cancer.

Sayeed A, Meng Z, Luciani G, Chen LC, Bennington JL, Dairkee SH.

Cell Death Dis. 2010 Jul 15;1:e53. doi: 10.1038/cddis.2010.30.

11.

Immutable functional attributes of histologic grade revealed by context-independent gene expression in primary breast cancer cells.

Dairkee SH, Sayeed A, Luciani G, Champion S, Meng Z, Jakkula LR, Feiler HS, Gray JW, Moore DH.

Cancer Res. 2009 Oct 1;69(19):7826-34. doi: 10.1158/0008-5472.CAN-09-1564. Epub 2009 Sep 29.

12.

Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients.

Dairkee SH, Seok J, Champion S, Sayeed A, Mindrinos M, Xiao W, Davis RW, Goodson WH.

Cancer Res. 2008 Apr 1;68(7):2076-80. doi: 10.1158/0008-5472.CAN-07-6526.

13.

Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.

Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, Moore DH, Schittulli F, Tommasi S, Paradiso A, Albertson DG, Benz CC.

Breast Cancer Res. 2007;9(5):R59.

14.

Oxidative stress pathways highlighted in tumor cell immortalization: association with breast cancer outcome.

Dairkee SH, Nicolau M, Sayeed A, Champion S, Ji Y, Moore DH, Yong B, Meng Z, Jeffrey SS.

Oncogene. 2007 Sep 20;26(43):6269-79. Epub 2007 Apr 30.

PMID:
17471242
15.

Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer.

Zhou Y, Yau C, Gray JW, Chew K, Dairkee SH, Moore DH, Eppenberger U, Eppenberger-Castori S, Benz CC.

BMC Cancer. 2007 Apr 3;7:59.

16.

In vitro anticancer activity of twelve Chinese medicinal herbs.

Shoemaker M, Hamilton B, Dairkee SH, Cohen I, Campbell MJ.

Phytother Res. 2005 Jul;19(7):649-51.

PMID:
16161030
17.

Aberrations of breast cancer susceptibility genes occur early in sporadic breast tumors and in acquisition of breast epithelial immortalization.

Meng ZH, Ben Y, Li Z, Chew K, Ljung BM, Lagios MD, Dairkee SH.

Genes Chromosomes Cancer. 2004 Nov;41(3):214-22.

PMID:
15334544
18.

A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue.

Dairkee SH, Ji Y, Ben Y, Moore DH, Meng Z, Jeffrey SS.

BMC Genomics. 2004 Jul 19;5(1):47.

19.

Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis.

Korkola JE, DeVries S, Fridlyand J, Hwang ES, Estep AL, Chen YY, Chew KL, Dairkee SH, Jensen RM, Waldman FM.

Cancer Res. 2003 Nov 1;63(21):7167-75.

20.

Genome-wide allelotyping of a new in vitro model system reveals early events in breast cancer progression.

Li Z, Meng ZH, Sayeed A, Shalaby R, Ljung BM, Dairkee SH.

Cancer Res. 2002 Oct 15;62(20):5980-7.

21.

Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer.

Li Z, Meng ZH, Chandrasekaran R, Kuo WL, Collins CC, Gray JW, Dairkee SH.

Cancer Res. 2002 Apr 1;62(7):1939-43.

22.

Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients.

Li Z, Moore DH, Meng ZH, Ljung BM, Gray JW, Dairkee SH.

Cancer Res. 2002 Feb 15;62(4):1000-3.

23.

Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene.

Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray JW, Pinkel D.

Nat Genet. 2000 Jun;25(2):144-6.

PMID:
10835626
24.

Propagation of genetically altered tumor cells derived from fine-needle aspirates of primary breast carcinoma.

Li Z, Bustos V, Miner J, Paulo E, Meng ZH, Zlotnikov G, Ljung BM, Dairkee SH.

Cancer Res. 1998 Dec 1;58(23):5271-4.

25.

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays.

Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW, Albertson DG.

Nat Genet. 1998 Oct;20(2):207-11.

PMID:
9771718
26.

The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers.

Chen LC, Manjeshwar S, Lu Y, Moore D, Ljung BM, Kuo WL, Dairkee SH, Wernick M, Collins C, Smith HS.

Cancer Res. 1998 Aug 15;58(16):3677-83.

27.

Partial enzymatic degradation of stroma allows enrichment and expansion of primary breast tumor cells.

Dairkee SH, Paulo EC, Traquina P, Moore DH, Ljung BM, Smith HS.

Cancer Res. 1997 Apr 15;57(8):1590-6.

28.

Genetic analysis of breast cancer progression.

Dairkee SH, Smith HS.

J Mammary Gland Biol Neoplasia. 1996 Apr;1(2):139-51. Review.

PMID:
10887488
29.

Selective cell culture of primary breast carcinoma.

Dairkee SH, Deng G, Stampfer MR, Waldman FM, Smith HS.

Cancer Res. 1995 Jun 15;55(12):2516-9.

30.

Immunohistochemical reactivity of basal and luminal epithelium-specific cytokeratin antibodies within normal and neoplastic canine mammary glands.

Griffey SM, Madewell BR, Dairkee SH, Hunt JE, Naydan DK, Higgins RJ.

Vet Pathol. 1993 Mar;30(2):155-61.

PMID:
7682368
31.

Differential retention of rhodamine 123 by breast carcinoma and normal human mammary tissue.

Dairkee SH, Hackett AJ.

Breast Cancer Res Treat. 1991 Mar;18(1):57-61.

PMID:
1854980
32.

Immunohistochemical demonstration of keratins 8 and 14 in benign tumours of the skin appendage.

Tsubura A, Okada H, Sasaki M, Dairkee SH, Morii S.

Virchows Arch A Pathol Anat Histopathol. 1991;418(6):503-7.

PMID:
1711732
33.

Loss of basal cell phenotype with acquisition of lung-colonizing capability in mouse mammary tumors.

Tsubura A, Inui T, Morii S, Dairkee SH, Oikawa T, Matsuzawa A.

Breast Cancer Res Treat. 1991 Jan-Feb;17(3):239-43.

PMID:
1710155
34.

Accessibility to intracellular antigens within nutritionally deprived human mammary epithelial cells.

Dairkee SH, Puett L, Counelis AM, Hackett AJ.

Exp Cell Res. 1991 Jan;192(1):182-8.

PMID:
1701725
35.

Immunolocalization of the human basal epithelial marker monoclonal antibody 312C8-1 in normal tissue and mammary tumours of rodents.

Tsubura A, Inui T, Senzaki H, Morii S, Dairkee SH.

Virchows Arch A Pathol Anat Histopathol. 1989;415(6):533-8.

PMID:
2477946
36.

Internal antigens accessible in breast cancer: implications for tumor targeting.

Dairkee SH, Hackett AJ.

J Natl Cancer Inst. 1988 Oct 5;80(15):1216-20.

PMID:
2458478
37.

Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue.

Dairkee SH, Puett L, Hackett AJ.

J Natl Cancer Inst. 1988 Jul 6;80(9):691-5.

PMID:
2453676
38.

Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicin.

Dollbaum C, Creasey AA, Dairkee SH, Hiller AJ, Rudolph AR, Lin L, Vitt C, Smith HS.

Proc Natl Acad Sci U S A. 1988 Jul;85(13):4740-4.

39.

Response of primary human mammary tumor cell cultures to a monoclonal antibody-recombinant ricin A chain immunotoxin.

Bjorn MJ, Smith HS, Dairkee SH.

Cancer Immunol Immunother. 1988;26(2):121-4.

PMID:
3258792
40.

Characterization of epimyoepithelial islands in benign lymphoepithelial lesions of major salivary gland: an immunohistochemical and ultrastructural study.

Dardick I, van Nostrand AW, Rippstein P, Skimming L, Hoppe D, Dairkee SH.

Head Neck Surg. 1988 Jan-Feb;10(3):168-78.

PMID:
3069810
41.

Warthin's tumor: an ultrastructural and immunohistochemical study of basilar epithelium.

Dardick I, Claude A, Parks WR, Hoppe D, Stinson J, Burns BF, Little J, Brown DL, Dairkee SH.

Ultrastruct Pathol. 1988;12(4):419-32. Review.

PMID:
2458648
42.

Immunohistochemistry and ultrastructure of myoepithelium and modified myoepithelium of the ducts of human major salivary glands: histogenetic implications for salivary gland tumors.

Dardick I, Rippstein P, Skimming L, Boivin M, Parks WR, Dairkee SH.

Oral Surg Oral Med Oral Pathol. 1987 Dec;64(6):703-15.

PMID:
3480487
43.

Immunolocalization of a human basal epithelium specific keratin in benign and malignant breast disease.

Dairkee SH, Ljung BM, Smith H, Hackett A.

Breast Cancer Res Treat. 1987 Oct;10(1):11-20.

PMID:
2446682
44.

Immortalization in culture: occurrence at a late stage in the progression of breast cancer.

Smith HS, Wolman SR, Dairkee SH, Hancock MC, Lippman M, Leff A, Hackett AJ.

J Natl Cancer Inst. 1987 Apr;78(4):611-5.

PMID:
3470538
45.

Monoclonal marker that predicts early recurrence of breast cancer.

Dairkee SH, Mayall BH, Smith HS, Hackett AJ.

Lancet. 1987 Feb 28;1(8531):514. No abstract available.

PMID:
2881076
46.

Concurrent expression of basal and luminal epithelial markers in cultures of normal human breast analyzed using monoclonal antibodies.

Dairkee SH, Blayney-Moore CM, Smith HS, Hackett AJ.

Differentiation. 1986;32(2):93-100.

PMID:
3792706
47.

Potential for cytologic breast fluid analysis in breast disease.

Dairkee SH, Hackett AJ.

Breast Cancer Res Treat. 1986;8(1):21-3. No abstract available.

PMID:
3790747
48.

Monoclonal antibody that defines human myoepithelium.

Dairkee SH, Blayney C, Smith HS, Hackett AJ.

Proc Natl Acad Sci U S A. 1985 Nov;82(21):7409-13.

49.

Early expression of vimentin in human mammary cultures.

Dairkee SH, Blayney CM, Asarnow DM, Smith HS, Hackett AJ.

In Vitro Cell Dev Biol. 1985 Jun;21(6):321-7.

PMID:
2410401
50.

Colony morphology on agar is a sensitive indicator for growth effectors.

Dairkee SH, Glaser DA.

Exp Cell Res. 1985 Jan;156(1):57-64.

PMID:
3880706

Supplemental Content

Loading ...
Support Center